Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Neuropathology and emerging biomarkers in corticobasal syndrome
S Koga, KA Josephs, I Aiba, M Yoshida… - Journal of Neurology …, 2022 - jnnp.bmj.com
Corticobasal syndrome (CBS) is a clinical syndrome characterised by progressive
asymmetric limb rigidity and apraxia with dystonia, myoclonus, cortical sensory loss and …
asymmetric limb rigidity and apraxia with dystonia, myoclonus, cortical sensory loss and …
Clinical spectrum of tauopathies
Tauopathies are both clinical and pathological heterogeneous disorders characterized by
neuronal and/or glial accumulation of misfolded tau protein. It is now well understood that …
neuronal and/or glial accumulation of misfolded tau protein. It is now well understood that …
Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains
ML Malarte, PG Gillberg, A Kumar, N Bogdanovic… - Molecular …, 2023 - nature.com
Recent mechanistic and structural studies have challenged the classical tauopathy
classification approach and revealed the complexity and heterogeneity of tau pathology in …
classification approach and revealed the complexity and heterogeneity of tau pathology in …
Tau PET imaging in neurodegenerative disorders
The advent of PET ligands that bind tau pathology has enabled the quantification and
visualization of tau pathology in aging and in Alzheimer disease (AD). There is strong …
visualization of tau pathology in aging and in Alzheimer disease (AD). There is strong …
Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer's disease tauopathies
A Lindberg, E Murrell, J Tong, NS Mason… - Nature …, 2024 - nature.com
Positron emission tomography (PET) imaging of tau aggregation in Alzheimer's disease
(AD) is hel** to map and quantify the in vivo progression of AD pathology. To date, no …
(AD) is hel** to map and quantify the in vivo progression of AD pathology. To date, no …
Overview of tau PET molecular imaging
GC Petersen, M Roytman, GC Chiang… - Current opinion in …, 2022 - journals.lww.com
Current Opinion in Neurology Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …
Amyloid and tau positron emission tomography imaging in Alzheimer's disease and other tauopathies
The detection and staging of Alzheimer's disease (AD) using non-invasive imaging
biomarkers is of substantial clinical importance. Positron emission tomography (PET) …
biomarkers is of substantial clinical importance. Positron emission tomography (PET) …
Magnetic resonance imaging measures to track atrophy progression in progressive supranuclear palsy in clinical trials
Background Several magnetic resonance imaging (MRI) measures have been suggested as
progression biomarkers in progressive supranuclear palsy (PSP), and some PSP staging …
progression biomarkers in progressive supranuclear palsy (PSP), and some PSP staging …
Amyloid-β prediction machine learning model using source-based morphometry across neurocognitive disorders
Y Momota, S Bun, J Hirano, K Kamiya, R Ueda… - Scientific reports, 2024 - nature.com
Previous studies have developed and explored magnetic resonance imaging (MRI)-based
machine learning models for predicting Alzheimer's disease (AD). However, limited research …
machine learning models for predicting Alzheimer's disease (AD). However, limited research …
A Machine Learning–Based Approach to Discrimination of Tauopathies Using [18F]PM‐PBB3 PET Images
H Endo, K Tagai, M Ono, Y Ikoma, A Oyama… - Movement …, 2022 - Wiley Online Library
Background We recently developed a positron emission tomography (PET) probe,[18F] PM‐
PBB3, to detect tau lesions in diverse tauopathies, including mixed three‐repeat and four …
PBB3, to detect tau lesions in diverse tauopathies, including mixed three‐repeat and four …